CORC

在结果中检索

CORC

浏览/检索结果: 共954条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Opportunities and challenges of fucoidan for tumors therapy 期刊论文
CARBOHYDRATE POLYMERS, 2024, 卷号: 324, 页码: 13
作者:  Yu, Haoyu;  Zhang, Quanbin;  Farooqi, Ammad Ahmad;  Wang, Jing;  Yue, Yang
收藏  |  浏览/下载：3/0  |  提交时间：2024/04/07
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong
收藏  |  浏览/下载：20/0  |  提交时间：2022/12/22
Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Guo-Zhen;  Ma, Li-Ying;  Zhang, Zong-Hui;  Wang, Xiao-Lin;  Hua, Jing-Han
收藏  |  浏览/下载：24/0  |  提交时间：2022/12/22
Influence of Dehydroxymethylepoxyquinomicin on Radiosensitivity of Thyroid Carcinoma TPC-1 Cells 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Liu, Jie;  Cai, Hu;  Yi, Heqing;  Li, Xin;  Peng, Yunsong
收藏  |  浏览/下载：13/0  |  提交时间：2022/12/22
Siglec-15 Silencing Inhibits Cell Proliferation and Promotes Cell Apoptosis by Inhibiting STAT1/STAT3 Signaling in Anaplastic Thyroid Carcinoma 期刊论文
DISEASE MARKERS, 2022, 卷号: 2022
作者:  Hou, Xiaofeng;  Chen, Chao;  He, Xiaodong;  Lan, Xiabin
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23
CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis 期刊论文
Molecular Cancer, 2022, 卷号: 21
作者:  Hua,Jinghan;  Wang,Xiaolin;  Ma,Liying;  Li,Jingxin;  Cao,Guozhen
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/22
Ratiometric co-delivery of hydroxychloroquine and calculated low-dose paclitaxel efficiently suppresses tumor growth in hepatocellular carcinoma mouse models in vivo 期刊论文
NANO TODAY, 2022, 卷号: 44
作者:  Wang, Wenbin;  Sun, Hui;  Gong, Yan;  Liu, Xiangsheng;  Liu, Xiao
收藏  |  浏览/下载：116/0  |  提交时间：2022/12/23
Inhibition of STAT3 Signaling Pathway by Terphenyllin Suppresses Growth and Metastasis of Gastric Cancer 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Yu, Dehua;  Qi, Simin;  Guan, Xiaoqing;  Yu, Wenkai;  Yu, Xuefei
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang
收藏  |  浏览/下载：92/0  |  提交时间：2022/03/28
EGPI-1, a novel eIF4E/eIF4G interaction inhibitor, inhibits lung cancer cell growth and angiogenesis through Ras/MNK/ERK/eIF4E signaling pathway 期刊论文
CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 卷号: 352, 页码: 10
作者:  Qi, Xueju;  Zhang, Shuna;  Chen, Zekun;  Wang, Lijun;  Zhu, Wenyong
收藏  |  浏览/下载：18/0  |  提交时间：2022/07/18

©版权所有 ©2017 CSpace - Powered by CSpace